Hi jimmy!
First of all, I do appreciate your input to this boar and read all your posts.
As to ALZ approval...
If ALZ approved, AVXL will be not 10, but maybe 100 bagger.
Lets assume, that the market size for ALZ alone is going to be
3 BILLION, then Gross profit of 75% and operating expense about 250 million lives us with 2 Billion profit! 2B/49 million shares results in EPS=$40
counting on the potential for revs of other indications and market growth, the PE could be 20, 30 and 40, etc...
$40*PE20 = $800 price per share(if no splits)...
Since all this assumptions and approximations, I purposely omitted corporate taxes, but not included potential revs from other indications, so its a wash...
That is why I think falconer was on target with his share price of $1000+ with the progression of business development....
After all ALZ trial failures by major BPs, the STREET is skeptical currently on AVXL success too. This is reflected in the share price, but upcoming events might change the sentiment...
Will see what CTAD presentations will bring...
Also it looks like that BIIB is going to license A273 for MS and it is going to give a huge boost to the AVXL stock price due to:
- validation of A2-73 platform by BP
- upfront money and royalties(???)
All IMHO.
P.S. thoughts in this direction improve my weekend mood...